Century Therapeutics (IPSC) Preferred Shares (2020)

Century Therapeutics (IPSC) posted quarterly Preferred Shares of $144.8 million for Q4 2020.

Century Therapeutics (IPSC) Preferred Shares (2020) Analysis & Trends

Century Therapeutics (IPSC) has reported Preferred Shares for 1 consecutive years, with $144.8 million the latest figure, recorded in Q4 2020.

In Q4 2020, Preferred Shares changed N/A year-over-year to $144.8 million; the TTM figure through Dec 2020 stood at $144.8 million (changed N/A YoY), while the FY2020 annual figure was $144.8 million, changed N/A from the prior year.
Preferred Shares was little changed at $144.8 million in Q4 2020 per IPSC's latest filing.
Across five years, Preferred Shares topped out at $144.8 million in Q4 2020 and bottomed at $144.8 million in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Century Therapeutics	346.65 Mn	86.58 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	144.84 Mn